Similar articles for PMID: 23210982

Year	Number of Results
2003	1
2005	2
2006	1
2007	2
2008	3
2009	3
2010	6
2011	12
2012	11
2013	7
2014	6
2015	9
2016	13
2017	15
2018	6
2019	3
2020	7
2021	3
2024	0

1

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma.

Peroja P, Pasanen AK, Haapasaari KM, Jantunen E, Soini Y, Turpeenniemi-Hujanen T, Bloigu R, Lilja L, Kuittinen O, Karihtala P. Peroja P, et al. Exp Hematol Oncol. 2012 Mar 26;1(1):2. doi: 10.1186/2162-3619-1-2. Exp Hematol Oncol. 2012. PMID: 23210982 Free PMC article.

2

Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas.

Pasanen AK, Kuitunen H, Haapasaari KM, Karihtala P, Kyllönen H, Soini Y, Turpeenniemi-Hujanen T, Kuittinen O. Pasanen AK, et al. Leuk Lymphoma. 2012 Apr;53(4):624-31. doi: 10.3109/10428194.2011.624226. Epub 2011 Dec 13. Leuk Lymphoma. 2012. PMID: 21929285

3

Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.

Bur H, Haapasaari KM, Turpeenniemi-Hujanen T, Kuittinen O, Auvinen P, Marin K, Koivunen P, Sormunen R, Soini Y, Karihtala P. Bur H, et al. Histopathology. 2014 Sep;65(3):319-27. doi: 10.1111/his.12389. Epub 2014 Apr 3. Histopathology. 2014. PMID: 24698430

4

Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.

de Oliveira Costa R, Hallack Neto A, Siqueira S, Lage LA, de Paula HM, Coutinho AM, Pereira J. de Oliveira Costa R, et al. Nucl Med Commun. 2016 Oct;37(10):1095-101. doi: 10.1097/MNM.0000000000000553. Nucl Med Commun. 2016. PMID: 27281359 Free PMC article. Clinical Trial.

5

Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone.

Hui D, Proctor B, Donaldson J, Shenkier T, Hoskins P, Klasa R, Savage K, Chhanabhai M, Gascoyne RD, Connors JM, Sehn LH. Hui D, et al. Leuk Lymphoma. 2010 Sep;51(9):1658-67. doi: 10.3109/10428194.2010.504872. Leuk Lymphoma. 2010. PMID: 20795790

6

Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.

Cheng CL, Huang SC, Chen JH, Wei CH, Fang WQ, Su TH, Yuan CT, Liu JH, Chuang MK, Tien HF. Cheng CL, et al. Oncologist. 2020 Sep;25(9):793-802. doi: 10.1634/theoncologist.2019-0756. Epub 2020 Apr 27. Oncologist. 2020. PMID: 32275807 Free PMC article.

7

The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.

Tadic L, Marjanovic G, Macukanovic-Golubovic L, Krstic M, Jevtovic-Stoimenov T, Kostov M, Smelcerovic Z, Stojanovic M. Tadic L, et al. J BUON. 2016 Sept-Oct;21(5):1259-1267. J BUON. 2016. PMID: 27837631 Free article.

8

Absolute Monocyte and Platelet Counts May Provide Additional Prognostic Information in Primary Gastric Diffuse Large B-cell Lymphoma Patients Treated with Rituximab and CHOP.

Spassov B, Vassileva D, Nikolov S, Ganeva P, Balatzenko G, Guenova M. Spassov B, et al. Folia Med (Plovdiv). 2020 Dec 31;62(4):785-801. doi: 10.3897/folmed.62.e51402. Folia Med (Plovdiv). 2020. PMID: 33415923

9

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.

Seo S, Hong JY, Yoon S, Yoo C, Park JH, Lee JB, Park CS, Huh J, Lee Y, Kim KW, Ryu JS, Kim SJ, Kim WS, Yoon DH, Suh C. Seo S, et al. Oncotarget. 2016 Nov 22;7(47):76934-76943. doi: 10.18632/oncotarget.12734. Oncotarget. 2016. PMID: 27764777 Free PMC article.

10

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.

Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, Chan WC. Iqbal J, et al. Clin Cancer Res. 2011 Dec 15;17(24):7785-95. doi: 10.1158/1078-0432.CCR-11-0267. Epub 2011 Sep 20. Clin Cancer Res. 2011. PMID: 21933893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year